What Gord Downie's Story Can Help Us Understand About Glioblastoma

What was made public

Gord Downie wrote and sang for The Tragically Hip for three decades. CBC News reported that his diagnosis was made public in May 2016. It reported that he died of glioblastoma. He and the band played a farewell tour that summer.

He and his bandmates raised money for brain cancer research. Beyond that, the details were his. His treatment, his scans and his choices were never made public. So this page says nothing about them.

What is worth explaining is the tumor. Glioblastoma is poorly understood outside brain cancer clinics. And the wrong ideas about it tend to be the bleak ones.

A tumor that has no edge

Glioblastoma is a glioma. That means it grows from the support cells of the brain, not from nerve cells. Brain tumors are graded I to IV by how aggressive the cells look. Glioblastoma is grade IV. That is the top of the scale.

The core problem is not size. It is the border. This tumor sends cells out along nerve fibers and blood vessels. They travel well past anything a scan can show. A surgeon can take out all that lights up on an MRI. Tumor cells can still be left behind, in brain that looks and works normally. That is why NCI says the cure rate is very low with standard local treatment.

NCI reports that glioblastomas and the related anaplastic astrocytomas make up about 38% of primary brain tumors. That is the largest single group.

How it is usually found

There is no screening test for brain tumors. There is no useful blood test either. This tumor shows itself through function. A growing mass presses on brain tissue that has a job to do.

So the first sign is often something no one can explain away. A first seizure in an adult. Weakness down one side. Words that will not come. A change in personality that the family sees first. Headaches that are worst on waking and come with vomiting.

An MRI with contrast often finds the tumor within hours in an emergency department. But a scan cannot name it. A pathologist has to look at tissue. That tissue comes from surgery or a needle biopsy. Gene tests on it now count for as much as the microscope. Our overview of how a cancer diagnosis is made explains why that step cannot be skipped.

When to get checked

Headaches almost never mean a brain tumor. These features are the ones that change the answer, and they deserve urgent medical attention rather than a wait:

• A first seizure at any age, with no known cause.
• Sudden weakness, numbness or clumsiness on one side. Or trouble speaking or understanding speech. Call emergency services. Stroke is the more likely cause, and every minute counts.
• Headache that is new and different from your usual headaches, worst on waking, and comes with vomiting.
• Vision that doubles or narrows, especially with headache.
• Confusion, memory loss, or a change in personality that develops over weeks.

What treatment involves

NCI sets out the standard plan for a new diagnosis. Surgery comes first. Then radiation, given at the same time as a daily chemotherapy tablet called temozolomide. Then about six more cycles of that tablet on its own.

In the trial that set that standard, the radiation dose was 60 gray. It was split into 2-gray daily doses over six weeks. It was aimed at the tumor plus a margin of two to three centimeters. The tablet was given daily during radiation. After a four-week break it was given as five-day courses every 28 days.

Surgery aims to take out as much tumor as is safe. How much that is depends on where it sits. Some people have a biopsy only. NCI also notes that adding bevacizumab did not help people live longer in two large trials. That drug targets the blood supply a tumor builds.

One marker that changes the estimate

Care now depends on gene tests run on the tumor tissue. One marker matters more than most.

MGMT is a gene. It makes an enzyme that repairs DNA. In some tumors the gene is switched off by a chemical tag. Those tumors repair chemotherapy damage less well. In one large trial, NCI reports median survival of 18.2 months when MGMT was switched off. It was 12.2 months when it was not.

CBC's report on Downie's death gave the Canadian picture. About 1,000 people are diagnosed each year. Average survival after diagnosis is about 18 months. Only about 4% are alive at five years or more.

In the United States, SEER covers a wider group. The American Cancer Society projects about 24,740 new malignant brain and nervous system cancers in 2026, and about 18,350 deaths, and SEER prints those projections. From NCI's own registry follow-up, the median age at diagnosis is 61 and five-year relative survival across that group is 32.9%. But that group holds many tumor types, most of them less aggressive. It is not a glioblastoma figure.

What this does not mean

Downie kept performing after his diagnosis. Many people admired that. It should not become a standard anyone is measured against. This tumor grows in the organ that produces thought, speech, energy and mood. So it changes all four. Many people cannot work. That is the disease, not the person.

Survival figures also cover groups treated years ago. They mix every age and every tumor subtype. Age, how much tumor came out, MGMT status and general health all pull one person's outlook far from the average.

And a brain tumor is not one condition. Many growths found in the brain are not cancer at all. Many others are far less aggressive than this one. Our guide to brain tumors sets out the range. Emotions and cancer covers the support that belongs beside treatment.

Sources

• CBC News: Glioblastoma, brain tumour that took Gord Downie's life, tough to treat, doctors say
• NCI PDQ: Central Nervous System Tumors Treatment (Health Professional Version)
• NCI SEER Cancer Stat Facts: Brain and Other Nervous System Cancer

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.